other material
confidence high
sentiment neutral
materiality 0.55
Cardiff Oncology rescinds 1.7M options, regrants same subject to stockholder approval
Cardiff Oncology, Inc.
- Board rescinded 1,697,712 options granted on March 7, 2024 at $3.51/share.
- Board regranted 1,697,712 options at same $3.51 strike, contingent on June 20, 2024 stockholder vote.
- Stockholder approval required to increase shares available under 2021 Equity Incentive Plan.
- Bylaw amended to align voting standards: plurality for directors, majority for other matters.